BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11883349)

  • 21. Controlled-release misoprostol vaginal insert in parous women for labor induction: a randomized controlled trial.
    Ewert K; Powers B; Robertson S; Alfirevic Z
    Obstet Gynecol; 2006 Nov; 108(5):1130-7. PubMed ID: 17077234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial of extra amniotic saline infusion with oxytocin versus prostaglandin E2 pessary for induction of labor.
    Mazhar SB; Imran R; Alam K
    J Coll Physicians Surg Pak; 2003 Jun; 13(6):317-20. PubMed ID: 12814527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Uterine hyperstimulation following cervix ripening with dinoprostone in a vaginal insert system].
    Brouwers JM; Briët JW; Brouwers JR
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1300-3. PubMed ID: 15279216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin F2 alpha gel and prostaglandin E2 pessary.
    Majoko F; Zwizwai M; Nyström L; Lindmark G
    Cent Afr J Med; 2002; 48(11-12):123-8. PubMed ID: 14562597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [PgE2 gel and PgE2 vaginal tablets for induced labor--a prospective randomized study].
    Mink D; Boos R; Heiss C; Schmidt W
    Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):409-13. PubMed ID: 7926574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Uterine reactions to prostaglandins in induced labor--results of a multicenter study].
    Mink D; Heiss C; Rath W; Schmidt W
    Zentralbl Gynakol; 1995; 117(1):35-9. PubMed ID: 7879461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 for cervical ripening: a multicenter study of patients with prior cesarean delivery.
    Flamm BL; Anton D; Goings JR; Newman J
    Am J Perinatol; 1997 Mar; 14(3):157-60. PubMed ID: 9259919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-induction cervical ripening: comparing between two vaginal preparations of dinoprostone in women with an unfavorable cervix.
    Ashwal E; Hiersch L; Melamed N; Manor Y; Wiznitzer A; Hod M; Yogev Y
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1874-9. PubMed ID: 24417462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term. The Prostaglandin E2 insert Study Group.
    Witter FR; Mercer BM
    J Matern Fetal Med; 1996; 5(2):64-9. PubMed ID: 8796770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Premature rupture of fetal membranes at term: an indication for induced labor with prostaglandins?].
    Lettau R; Hege G; Steldinger R
    Zentralbl Gynakol; 1995; 117(3):121-5. PubMed ID: 7740844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial.
    Denguezli W; Trimech A; Haddad A; Hajjaji A; Saidani Z; Faleh R; Sakouhi M
    Arch Gynecol Obstet; 2007 Aug; 276(2):119-24. PubMed ID: 17219155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term.
    Shetty A; Livingstone I; Acharya S; Rice P; Danielian P; Templeton A
    BJOG; 2004 May; 111(5):436-40. PubMed ID: 15104606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine rupture during induced trial of labor among women with previous cesarean delivery.
    Ravasia DJ; Wood SL; Pollard JK
    Am J Obstet Gynecol; 2000 Nov; 183(5):1176-9. PubMed ID: 11084562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of low-dose oxytocin and dinoprostone for labor induction in postterm pregnancies: a randomized controlled prospective study.
    Akay NÖ; Hızlı D; Yılmaz SS; Yalvaç S; Kandemir O
    Gynecol Obstet Invest; 2012; 73(3):242-7. PubMed ID: 22433939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytocin-induced labor characteristics and uterine activity after preinduction cervical priming with prostaglandin E2 intracervical gel.
    Ferguson JE; Ueland FR; Stevenson DK; Ueland K
    Obstet Gynecol; 1988 Nov; 72(5):739-45. PubMed ID: 3173925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Uterine activity in induction of labor by vaginal administration of prostaglandin E2 tablets].
    Egarter C; Philipp K; Skodler D; Kofler E
    Z Geburtshilfe Perinatol; 1986; 190(3):129-32. PubMed ID: 3464139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised controlled trial comparing low dose vaginal misoprostol and dinoprostone vaginal gel for inducing labour at term.
    Gregson S; Waterstone M; Norman I; Murrells T
    BJOG; 2005 Apr; 112(4):438-44. PubMed ID: 15777441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized clinical trial comparing vaginal misoprostol versus cervical Foley plus oral misoprostol for cervical ripening and labor induction.
    Hill JB; Thigpen BD; Bofill JA; Magann E; Moore LE; Martin JN
    Am J Perinatol; 2009 Jan; 26(1):33-8. PubMed ID: 18850516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obstetric outcomes after cervical ripening by multiple doses of vaginal prostaglandin E2.
    Chan LY; Fu L; Leung TN; Wong SF; Lau TK
    Acta Obstet Gynecol Scand; 2004 Jan; 83(1):70-4. PubMed ID: 14678088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial of preinduction cervical ripening: dinoprostone vaginal insert versus double-balloon catheter.
    Cromi A; Ghezzi F; Uccella S; Agosti M; Serati M; Marchitelli G; Bolis P
    Am J Obstet Gynecol; 2012 Aug; 207(2):125.e1-7. PubMed ID: 22704766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.